Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Beta This is a new resource - your feedback will help us improve it.

Series: Comparison of Average Sales Prices and Average Manufacturer Prices

Announced on  | Last Modified on  | Series Number: SRS-E-27-001

OBJECTIVE

When Congress established average sales price (ASP) as the basis for Medicare Part B drug reimbursement, it also provided a mechanism for monitoring market prices and limiting potentially excessive Medicare payment amounts.  Section 1847A(d)(1)-(3) of the Social Security Act mandates that OIG compare ASPs with average manufacturer prices (AMPs) and widely available market prices (WAMPs) (if any).  If OIG finds that the ASP for a drug exceeds the AMP by 5 percent in the two previous quarters or three of the previous four quarters, the Secretary of Health and Human Services may substitute the reimbursement amount with a lower calculated rate.

There are 4 projects in this series.

ACTIVE PROJECTS IN THIS SERIES (4)

Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Second Quarter of 2026

Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Third Quarter of 2026

Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Fourth Quarter of 2026

Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the First Quarter of 2027

TIMELINE

  • November 16, 2026
    Series Number SRS-E-27-001 Assigned
  • November 16, 2026
    Projects Announced

    Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Second Quarter of 2026 - OEI-03-27-00010

  • Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Third Quarter of 2026 - OEI-03-27-00020

  • Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Fourth Quarter of 2026 - OEI-03-27-00030

  • Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the First Quarter of 2027 - OEI-03-27-00040

  • Today
    4 Evaluations In-Progress
  • Est FY2027
    Estimated Fiscal Year for Series Completion